TIMP3 and lung adenocarcinoma: Interestingly, Chang et al. revealed that patients carrying T/T in TIMP-3 rs9862 exhibited a higher risk of presenting mutant epidermal growth factor receptor (EGFR), as compared to those with CC, in lung adenocarcinoma.